Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO00635)
Xenobiotics Name
Piperine
Xenobiotics Type
Pharmaceutical Agent(s)
Classification
Drug in Phase 1 Clinical Trial
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=638024"></iframe>
3D MOL 2D MOL
PubChem CID
638024
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
Catalase (CAT) DME Info Homo sapiens [1]
DME(s) Induced by This Xenobiotics
Cytochrome P450 3A4 (CYP3A4) DME Info Homo sapiens [2]
References
1 Synthesis, characterization, antioxidant, antidiabetic, anticholinergic, and antiepileptic properties of novel N-substituted tetrahydropyrimidines based on phenylthiourea. J Biochem Mol Toxicol. 2018 Dec;32(12):e22221.
2 Effects of phenyl saligenin phosphate on cell viability and transglutaminase activity in N2a neuroblastoma and HepG2 hepatoma cell lines. Toxicol In Vitro. 2009 Dec;23(8):1559-63.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.